Skip to content
HowShorted

COLLEGIUM PHARMACEUTICAL, INC short interest in 2024

In 2024, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 19.46% of shares outstanding on 12 Jan 2024 to 18.55% on 31 Dec 2024, a change of -0.91 percentage points. The year's high was 22.27% on 28 Mar 2024 and its low 18.43% on 30 Sep 2024, averaging 20.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.83 days on 13 Sep 2024. Full history: COLLEGIUM PHARMACEUTICAL, INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for COLLEGIUM PHARMACEUTICAL, INC in 2024

2024 in figures

Start of year
19.46% (12 Jan 2024)
End of year
18.55% (31 Dec 2024)
Change
-0.91 pp
High
22.27% (28 Mar 2024)
Low
18.43% (30 Sep 2024)
Average
20.19%
Highest days to cover
27.83 (13 Sep 2024)
SEC filings marked
9

Every report in 2024

COLLEGIUM PHARMACEUTICAL, INC short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202419.46%9.76
31 Jan 202421.14%23.67
15 Feb 202421.34%24.28
29 Feb 202421.01%11.6910-K filed, results (8-K)
15 Mar 202421.93%13.65
28 Mar 202422.27%14.32
15 Apr 202421.86%21.31
30 Apr 202420.96%21.11
15 May 202421.20%10.7310-Q filed, results (8-K)
31 May 202420.93%16.48
14 Jun 202420.25%13.99
28 Jun 202421.23%9.33
15 Jul 202421.15%26.08
31 Jul 202419.30%10.67results (8-K)
15 Aug 202418.98%12.5510-Q filed, results (8-K)
30 Aug 202419.52%21.13
13 Sep 202419.72%27.83
30 Sep 202418.43%11.99
15 Oct 202419.08%14.57
31 Oct 202419.25%23.61
15 Nov 202419.49%11.2810-Q filed, results (8-K)
29 Nov 202418.94%13.28
13 Dec 202418.57%13.29
31 Dec 202418.55%12.76

See also: COLLEGIUM PHARMACEUTICAL, INC's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.